Head to head comparison of Myfortic [mycophenolate sodium] vs. Cellcept [mycophenolate mofetil] in the treatment of kidney transplant recipients using our current center standardized concomitant immunosuppressive protocol

Trial Profile

Head to head comparison of Myfortic [mycophenolate sodium] vs. Cellcept [mycophenolate mofetil] in the treatment of kidney transplant recipients using our current center standardized concomitant immunosuppressive protocol

Completed
Phase of Trial: Phase II/III

Latest Information Update: 06 Oct 2007

At a glance

  • Drugs Mycophenolate mofetil; Mycophenolate sodium
  • Indications Renal transplant rejection
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 06 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top